iShares iBonds Dec 2026 Term Corporate ETF
IBDR
439 hedge funds and large institutions have $2.63B invested in iShares iBonds Dec 2026 Term Corporate ETF in 2026 Q1 according to their latest regulatory filings, with 46 funds opening new positions, 179 increasing their positions, 146 reducing their positions, and 33 closing their positions.
39% more first-time investments, than exits
New positions opened: 46 | Existing positions closed: 33
23% more repeat investments, than reductions
Existing positions increased: 179 | Existing positions reduced: 146
1% more funds holding
Funds holding: 436 → 439 (+3)
3.88% less ownership
Funds ownership: 68.12% → 64.23% (-3.9%)
6% less capital invested
Capital invested by funds: $2.79B → $2.63B (-$167M)
10% less funds holding in top 10
Funds holding in top 10: 21 → 19 (-2)
Top Buyers
Top Sellers
IBDR Hedge Fund Activity: Q1 2026 in Review
439 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in iShares iBonds Dec 2026 Term Corporate ETF (IBDR) for Q1 2026, worth a combined $2.63B — down 6% from $2.79B a quarter earlier.
Buyers outnumbered sellers: 46 funds opened new IBDR positions and 33 closed out — a net gain of 13 holders — while 179 added to existing stakes and 146 trimmed.
The largest buyer was Mesirow Financial Investment Management, adding an estimated $10.6M. The largest seller was Sarver Vrooman Wealth Advisors, cutting an estimated $42.9M.
- 439 institutional investors held iShares iBonds Dec 2026 Term Corporate ETF (IBDR) as of Q1 2026, up from 436 in Q4 2025.
- Funds reported $2.63B of iShares iBonds Dec 2026 Term Corporate ETF stock for Q1 2026, down 6% quarter-over-quarter.
- 46 funds opened new iShares iBonds Dec 2026 Term Corporate ETF positions in Q1 2026 and 33 closed out, a net change of +13 holders.
- The largest iShares iBonds Dec 2026 Term Corporate ETF buyer in Q1 2026 was Mesirow Financial Investment Management, an estimated $10.6M added.
- The largest iShares iBonds Dec 2026 Term Corporate ETF seller in Q1 2026 was Sarver Vrooman Wealth Advisors, an estimated $42.9M sold.
Based on aggregated 13F filings for Q1 2026.